Osprey Medical

Osprey Medical

Osprey Medical

MOsprey Medical develops and commercializes its propriety CINCOR™ Systemdesigned for the prevention of Contrast Induced Nephropathy.
Founded
2005
Raised
$67.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$26,000,000
Post-IPO equity - 2017
$25,000,000
Venture capital - 2016
Canaccord Genuity Bill Potter
Team Size
10+
Employees
$26,000,000 Post-IPO equity
Star Tribune , MassDevice

Osprey Medical raises $26M, plans to expand sales force

$25,000,000 Venture capital
Financial Review

Osprey Medical seeks $25m equity injection